Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

15 projects found matching your search criteria :

  1. Next generation in vitro experimental model of melanoma for pharmacological studies

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Małgorzata Ewa Czyż

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  2. Inhibition of 'side effects' related to tumor-associated macrophages activity in canine mammary cancer

    Call: SONATA 5 , Panel: NZ5

    Principal investigator: dr hab. Magdalena Król

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  3. The influence of metabolic pathway inhibitors on the development and quality of bovine embryos produced in vitro.

    Call: OPUS 3 , Panel: NZ9

    Principal investigator: dr hab. Dorota Marta Cieślak

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

  4. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  5. Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier in...

    Call: POLONEZ BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Aneta Iwona Radziwon-Balicka

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  6. Targeted inhibition of hypusination pathway

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr Przemysław Marek Grudnik

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  7. Combinatorial targeting of non-genetic sources of cell-to-cell heterogeneity to overcome fractional killing of cancer ce...

    Call: SONATA 17 , Panel: NZ3

    Principal investigator: dr Jarosław Walczak

    Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk

  8. Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr hab. Carlo Vascotto

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  9. Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental thera...

    Call: CHIST-ERA2020 , Panel: NZ7

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński

  10. Effect of therapy with selective serotonin reuptake inhibitors and physical exercise on blood brain barrier permeability...

    Call: PRELUDIUM 17 , Panel: NZ5

    Principal investigator: Marta Anna Małkiewicz

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

  11. Histidine Biosynthetic Pathway in Plants: Structural and Functional Studies as a Framework for the Design of Inhibitors ...

    Call: SONATA 14 , Panel: NZ1

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  12. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the colorectal cancer treatment

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: prof. Adam Janusz Dziki

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  13. Unravelling the molecular/ genetic network of hyperycin biosynthesis by employing innovative tools.

    Call: OPUS 12 , Panel: NZ9

    Principal investigator: dr Franklin Gregory

    Instytut Genetyki Roślin Polskiej Akademii Nauk

  14. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the primary open-angle glaucoma treatmen...

    Call: OPUS 11 , Panel: NZ5

    Principal investigator: prof. Ireneusz Jacek Majsterek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  15. New opportunities for use of PERK kinase inhibitors in eIF2alfa factor-dependant signalling pathway in antitumor therapy

    Call: PRELUDIUM 10 , Panel: NZ3

    Principal investigator: dr Wioletta Julia Rozpędek-Kamińska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski